Aging and the role of reactive nitrogen species

Annals of the New York Academy of Sciences

Volumn 959, Issue , 2002, Pages 66-81

  Drew, Barry ^a   Leeuwenburgh, Christiaan ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Apoptosis; Denitrase; Nitric oxide; Oxidants; Protein nitration

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AGED; AGING; APOPTOSIS; CELL DAMAGE; CELL DEATH; CONFERENCE PAPER; ENZYME ACTIVITY; MOUSE; NITRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION;

EID: 0036236271     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02084.x     Document Type: Conference Paper

References (114)

1. Nitric oxide activates guanylate cyclase and increases guanosine 3′: 5′-cyclic monophosphate levels in various tissue preparations
2. The molecule of the year
3. Nobel prize in Medicine and Physiology 1998 for the discovery of the role of nitric oxide as a signalling molecule
4. Research tools for nitric oxide
5. Inducible NO synthase: Role in cellular signalling
6. Distinct and specific functions of cGMP-dependent protein kinases
7. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3)
8. Tailoring cAMP-signalling responses through isoform multiplicity
9. Structure and function of cyclic nucleotidegated channels
10. Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats
11. Oxidants, antioxidants, and the degenerative diseases of aging
12. The flux of free radical attack through mitochondrial DNA is related to aging rate
13. Molecular mechanisms of oxidative stress and aging: Free radicals, aging, antioxidants, and disease
14. Relationship between antioxidants, prooxidants, and the aging process
15. Aging, energy, and oxidative stress in neurodegenerative diseases
16. Understanding the causes of aging and cancer
17. Free radicals, antioxidants and ageing
18. Antioxidants and aging
19. Nitric oxide and chronic HCV and HIV infections
20. Antioxidants, oxidative stress, and degenerative neurological disorders
21. Nitric oxide dependent vasodilation in young spontaneously hypertensive rats
22. Endothelial function and dysfunction in heart failure
23. Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure
24. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions
25. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin - Converting enzyme in patients with lung cancer
26. Nitric oxide synthase expression in lungs of pulmonary hypertensive patients with heart disease
27. Nitric oxide synthase II gene disruption: Implications for tumor growth and vascular endothelial growth factor production
28. Reactive nitrogen species in colon carcinogenesis
29. Polymorphic markers of endothelial NO-synthase and angiotensin II vascular receptor genes and predisposition to ischemic heart disease
30. Nitric oxide synthase activity in peripheral polymorphonuclear leukocytes in patients with chronic congestive heart failure
31. Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3
32. Expression and function of inducible nitric oxide synthase in neurons
33. The role of nitric oxide in the failing heart
34. Specificity of inducible nitric-oxide synthase inhibitors: Prospects for their clinical therapy
35. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress
36. Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles
37. Nitric oxide in skeletal muscle
38. Endothelial type nitric oxide synthase in skeletal muscle fibers: Mitochondrial relationships
39. Nitric oxide release and contractile properties of skeletal muscles from mice deficient in type III NOS
40. Decrease of neuronal nitric oxide synthase in the cerebellum of aged rats
41. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity
42. Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis
43. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase
44. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs
45. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat
46. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase
47. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase
48. Basal nitric oxide synthesis in essential hypertension
49. Nitric oxide: Physiology, pathophysiology, and pharmacology
50. Regulation of biosynthesis of nitric oxide
51. Therapeutic strategies for the inhibition of inducible nitric oxide synthase - Potential for a novel class of anti-inflammatory agents
52. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase
53. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells
54. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism
55. Inducible nitric oxide: An autoregulatory feedback inhibitor of vascular inflammation
56. Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29
57. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B
58. Protective action of nitrone-based free radical traps against oxidative damage to the central nervous system
59. Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps
60. Nitrone inhibition of age-associated oxidative damage
61. Production of nitric oxide by mitochondria
62. Purification and characterization of a nitric-oxide synthase from rat liver mitochondria
63. The modulation of oxygen radical production by nitric oxide in mitochondria
64. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation
65. Nitrotyrosine as biomarker for reactive nitrogen species
66. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification
67. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine
68. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity
69. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma
70. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite
71. Peroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins
72. Protein oxidation and age-dependent alterations in calcium homeostasis
73. Chemical influences on the specificity of tyrosine phosphorylation
74. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
75. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation
76. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide
77. Inhibition of nitric oxide synthesis accentuates blood pressure elevation in hyperinsulinemic rats
78. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
79. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase
80. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not
81. Age-linked changes in the activity of enzymes of the tricarboxylate cycle and lipid oxidation, and of carnitine content, in muscles of the rat
82. Oxidative damage during aging targets mitochondrial aconitase
83. Comparison between developmental and senescent changes in enzyme activities linked to energy metabolism in rat heart
84. Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in ageing
85. Liver mitochondrial respiratory functions decline with age
86. Oxidative energy failure in post-mitotic cells: A major factor in senescence
87. Decline in skeletal muscle mitochondrial respiration chain function with ageing
88. Apoptosis: A two-edged sword in aging
89. What does cell death have to do with aging?
90. Aging and regulation of apoptosis
91. Apoptosis and exercise
92. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
93. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
94. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima
95. Widespread peroxynitrite-mediated damage in Alzheimer's disease
96. Interventions based on the possibility that oxidative stress contributes to sarcopenia
97. Protein oxidation and proteolysis during aging and oxidative stress
98. Protein oxidation and aging
99. Mitochondria contain a proteolytic system which can recognize and degrade oxidatively-denatured proteins
100. Protein degradation as an index of oxidative stress
101. Protein damage and degradation by oxygen radicals. I. General aspects
102. Dityrosine: A marker for oxidatively modified proteins and selective proteolysis
103. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome
104. Proteolytic degradation of tyrosine nitrated proteins
105. An activity in rat tissues that modifies nitrotyrosine-containing proteins
106. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle
107. Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca-ATPase of rat skeletal muscle during aging: A peroxynitrite-mediated process?
108. The oxidative inactivation of sarcoplasmic reticulum Ca(2+)-ATPase by peroxynitrite
109. Age-associated changes in nitric oxide metabolites nitrite and nitrate
110. Distribution of nitrogen-13 from labeled nitrate (13No3-) in humans and rats
111. Meat consumption and colorectal cancer: A review of epidemiologic evidence
112. Chemical studies on tobacco smoke LVI. Tobacco specific nitrosamines: Origins, carcinogenicity and metabolism